Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP456121.RAS9F7h92q9LDL1s0WpzDXE7inxWYh2isC3LW_CRs-rZc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP456121.RAS9F7h92q9LDL1s0WpzDXE7inxWYh2isC3LW_CRs-rZc130_assertion type Assertion NP456121.RAS9F7h92q9LDL1s0WpzDXE7inxWYh2isC3LW_CRs-rZc130_head.
- NP456121.RAS9F7h92q9LDL1s0WpzDXE7inxWYh2isC3LW_CRs-rZc130_assertion description "[Initial studies have shown that BRAF mutations occur at a high frequency in melanocytic nevi and metastatic lesions, but recent data have revealed much lower incidence of these mutations in early-stage melanoma, implying that other factors may contribute to melanoma pathogenesis in a wild-type (WT) BRAF context.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP456121.RAS9F7h92q9LDL1s0WpzDXE7inxWYh2isC3LW_CRs-rZc130_provenance.
- NP456121.RAS9F7h92q9LDL1s0WpzDXE7inxWYh2isC3LW_CRs-rZc130_assertion evidence source_evidence_literature NP456121.RAS9F7h92q9LDL1s0WpzDXE7inxWYh2isC3LW_CRs-rZc130_provenance.
- NP456121.RAS9F7h92q9LDL1s0WpzDXE7inxWYh2isC3LW_CRs-rZc130_assertion SIO_000772 15313890 NP456121.RAS9F7h92q9LDL1s0WpzDXE7inxWYh2isC3LW_CRs-rZc130_provenance.
- NP456121.RAS9F7h92q9LDL1s0WpzDXE7inxWYh2isC3LW_CRs-rZc130_assertion wasDerivedFrom befree-2016 NP456121.RAS9F7h92q9LDL1s0WpzDXE7inxWYh2isC3LW_CRs-rZc130_provenance.
- NP456121.RAS9F7h92q9LDL1s0WpzDXE7inxWYh2isC3LW_CRs-rZc130_assertion wasGeneratedBy ECO_0000203 NP456121.RAS9F7h92q9LDL1s0WpzDXE7inxWYh2isC3LW_CRs-rZc130_provenance.